DNA World California 4-Embarcadero Center, San Francisco, CA 94111, USA.
info@dnaworld.org
+1 213 545—1021

Screening Today For Healthier Tomorrow

Parents put their children’s health and welfare first above all else. Those with newborn babies make sure to follow their doctor’s recommendations on keeping their infants safe and in excellent health. However, there are health conditions that are not apparent at birth or will only show symptoms later. Thankfully, a medical procedure called newborn screening can help identify serious and rare health conditions in newborn babies, letting parents know about the presence of issues that need to be addressed or treated right away even before symptoms manifest.

Why Newborn Screening is Offered?

Most babies are healthy and won’t have any of the conditions the screening tests are looking for. But for those babies who do have a health problem, the benefits of screening can be enormous. Early treatment can improve their health and prevent severe disability or even death. The screening tests are quick and simple, and won’t harm your baby in any way. It’s recommended that your baby has the tests.

Newborn DNA Test is Extensive

Newborn screening detects 200+ childhood conditions to give you a more comprehensive insight into your baby’s health. Many of these conditions can’t be detected by carrier screening, standard prenatal tests, or state newborn screening.

Newborn DNA Test is Actionable

This test only includes conditions that may be treated with medicine, dietary modifications, or other therapies, so you and your pediatrician can take proactive steps to care for your child’s health.

Newborn DNA Test is Accurate & Gentle

Our advanced DNA sequencing technology to detect changes in your baby’s genes with >95% accuracy. Learn more about the accuracy of this test. No heel pricks are necessary. Our cheek swab is designed for gentle and simple testing.

What We Test?

Our Supplemental Metabolic Newborn Screening Panel analyzes genes associated with metabolic conditions that are in the differential diagnosis for metabolic newborn screening disorders or may present in the newborn period but are not screened for by U.S. or state newborn screening. Our Supplemental Metabolic Newborn Screening Panel may be appropriate also for symptomatic infants, premature infants, or babies in the neonatal intensive care unit who have similar or overlapping clinical symptoms with metabolic newborn screening disorders.

A4GALT ACAD9 ALDH18A1 ALG1ALG11 ALG12 ALG13 ALG14ALG2 ALG3 ALG6 ALG8ALG9 ARCN1 ATP13A2 ATP6AP1ATP6AP2 ATP6V0A2 ATP6V1A ATP6V1E1B3GALNT2 B3GALT6 B3GAT3 B3GLCTB4GALNT1 B4GALT1 B4GALT7 B4GAT1BOLA3 C1GALT1C1 CA5A CADCANT1 CCDC115 CHST14 CHST3CHST6 CHSY1 CLN2 (TPP1) CLN3CLN5 CLN6 CLN8 COG1COG2 COG4 COG5 COG6COG7 COG8 COPA COPB2CSGALNACT1 CTSD CYP27A1 D2HGDHDDOST DHCR7 DHDDS DOLKDPAGT1 DPM1 DPM2 DPM3DSE EOGT EXT1 EXT2EXTL3 FKRP FKTN FUKFUT8 G6PC3 GALNT3 GANABGFPT1 GLRX5 GLUL GM2AGMPPA GMPPB GNE GNPTABGNS GORAB GOSR2 GPAA1HEXA HEXB HGSNAT HMGCS2IBA57 ISCA2 ISPD JAGN1KCTD7 LARGE1 LFNG LIASLIPT1 LIPT2 MAGT1 MAN1B1MFSD8 MGAT2 MOGS MPDU1MPI NAGLU NANS NFU1NGLY1 NPC1 NPC2 NUS1OGT OXCT1 PAPSS2 PGAP1PGAP2 PGAP3 PGM3 PIGAPIGB PIGC PIGG PIGLPIGM PIGN PIGO PIGPPIGQ PIGT PIGU PIGVPIGW PIGY PMM2 POFUT1POGLUT1 POMGNT1 POMGNT2 POMKPOMT1 POMT2 PPT1 PRKCSHRFT1 RPN2 RXYLT1 SAR1BSEC23A SEC23B SEC24D SEC63SGSH SLC10A7 SLC16A1 SLC26A2SLC35A1 SLC35A2 SLC35A3 SLC35C1SLC35D1 SLC37A4 SLC39A8 SLC6A9SLC7A7 SLC9A7 SRD5A3 SSR3SSR4 ST3GAL3 ST3GAL5 STT3ASTT3B TGDS TMEM165 TMEM199TRAK1 TRAPPC11 TRAPPC12 TRAPPC2TRAPPC6B TRAPPC9 TRIP11 TUSC3VMA21 VPS13B XYLT1 XYLT2

Newborn screening detects 200+ childhood conditions to give you a more comprehensive insight into your baby’s health. If you need the full list of disorders, please contact us.

Disorders on the Supplemental Metabolic Newborn Screening Panel follow a variety of inheritance patterns including autosomal recessive, autosomal dominant, and X-linked. Several conditions follow both autosomal recessive and autosomal dominant inheritance. Conditions associated with mitochondrial inheritance and repeat expansions are not evaluated by this panel.

About 1 in 4 children* are expected to screen positive for a condition on the newborn panel. Most babies who are born with these conditions appear healthy at first. This means that a disease may not be diagnosed until symptoms appear. Early screening with a newborn DNA Test can help you and your pediatrician know whether to take proactive steps, sooner, to care for your baby’s health.

Our Lab is a College of American Pathologists (CAP)-accredited and Clinical Laboratory Improvement Amendments (CLIA)-certified clinical diagnostic laboratory performing full-gene sequencing and deletion/duplication analysis using next-generation sequencing technology (NGS).

Our sequence analysis covers clinically important regions of each gene, including coding exons and 10 to 20 base pairs of adjacent intronic sequences on either side of the coding exons in the transcript listed below, depending on the specific gene or test. In addition, the analysis covers select non-coding variants. Any variants that fall outside these regions are not analyzed. Any limitations in the analysis of these genes will be listed in the report. Contact our client services with any questions.

How it Works?

The process is as simple as ordering a kit from our lab. When it arrives after 3 business days, you will collect a saliva sample with a quick cheek swab provided in the kit. Then, just send it back in the prepaid mailer, and we will send it to our Lab in the USA. Your results will be ready in 2-4 weeks. (Average time 3 weeks).